Navigation Links
Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011
Date:2/1/2011

royalty initiation fees related to new licensing agreements in the first quarter of fiscal 2011. Royalty initiation fees in the second quarter of fiscal 2011 were not material.

Selling, general and administrative expenses for the quarter and six months ended December 31, 2010 decreased $642,000 (7.1%) and $1.1 million (6.6%) from the quarter and six months ended December 31, 2009. The decrease in selling, general and administrative expense for the quarter and six months resulted primarily from decreased legal expenses, lower printing costs due to the timing of the printing of the annual Biotechnology catalog and the effect of the change in exchange rates used to convert foreign expenses to U.S. dollars.

Research and development expenses for the quarter and six months ended December 31, 2010 increased $212,000 (3.3%) and $677,000 (5.4%) from the quarter and six months ended December 31, 2009.  The increase in research and development expenses is mainly due to increases in personnel and supply costs associated with the continuous development and release of new high-quality biotechnology products.

The effective tax rate for the quarter and six months ended December 31, 2010 was 29.6% and 31.0% as compared to 32.6% for both of the same prior-year periods. The improvement in the effective tax rate in fiscal 2011 was the result of renewal of the U.S. research and development credit discussed above and an increase in the deduction for qualified production activities.  

Forward Looking Statements:

Our press releases may contain forward-looking statements within the meaning of the Private Litigation Reform Act. Such statements involve risks and uncertainties that may affect the actual results of operations. The following important factors, among others, have affected and, in the future, could affect the Company's actual results: the introduction and acceptance of new biotechnology and hematology products, the levels and particula
'/>"/>

SOURCE Techne Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Techne Corporation Announces That Dr. Roeland Nusse Has Accepted a Seat on Its Board of Directors
2. Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010
3. Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009
4. Techne Corporation Declares Dividend
5. TechNet Urges Swift U.S. Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell
6. Techne Corporation Board Member Recognized
7. Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors
8. Techne Corporation Announces That John L. Higgins has Accepted a Seat on Technes Board
9. Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009
10. Techne Corporation Declares Dividend and Announces an Increase in Its Share Repurchase Program
11. Techne Corporation Declares Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014 Reportlinker.com announces ... available in its catalogue: Global ... http://www.reportlinker.com/p02316661/Global-Biodegradable-Packaging-Materials-Market-2014-2018.html About ... that are readily decomposed by the action ... non-degradable packaging in terms of raw materials, ...
(Date:8/27/2014)... 27, 2014 Research and Markets ... Lactic Acid  (Biodegradable Polymer, Food & Beverage, Personal ... to 2019" report to their offering. ... with an asymmetrical carbon atom. The main applications ... food and beverage, personal care product, and pharmaceutical ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportbuyer.com ... The Graphene Opportunity - A Rational View ... Graphene The New Nanotech? A similar amount ... of applications ranging from microelectronics to water treatment, ... announced the availability of the Graphene Opportunity Report, ...
(Date:8/27/2014)... JUNCTION, N.J. , Aug. 27, 2014 ... innovative drug delivery technologies, today announced that it has ... Jersey Business & Industry Association,s 2014 Awards for ... were selected by an independent panel of judges from ... company volunteers. Award winners will be honored at a ...
Breaking Biology Technology:Global Biodegradable Packaging Materials Market 2014-2018 2Global Biodegradable Packaging Materials Market 2014-2018 3Global Biodegradable Packaging Materials Market 2014-2018 4Global Biodegradable Packaging Materials Market 2014-2018 5Global Biodegradable Packaging Materials Market 2014-2018 6Global Biodegradable Packaging Materials Market 2014-2018 7Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2The Graphene Opportunity - A Rational View 2The Graphene Opportunity - A Rational View 3The Graphene Opportunity - A Rational View 4Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2
... SUNNYVALE, Calif., Nov. 13 Voler,( http://www.volersystems.com ) ... design capabilities beyond prototypes and custom test,systems to ... human use.,"Voler continues to invest in upgrades to ... our multidisciplinary team," stated Walt Maclay,president of Voler. ...
... Future Healthcare and Education, OLDSMAR, Fla., Nov. ... largest and most established private,cord blood banks and ... agreement as an exclusive retailer with Upromise(R) the,largest ... Since,2004, Cryo-Cell has been the only cord blood ...
... Requires Only Weekly Dosing, SAN DIEGO, Nov. ... trial data demonstrating that ARX201, the company,s,long-acting human ... Serono, normalized insulin-like growth factor I (IGF-I) levels,while ... adults,with Growth Hormone deficiency. The results of this ...
Cached Biology Technology:Voler Expands Medical Device Design Capabilities 2Voler Expands Medical Device Design Capabilities 3Cryo-Cell Renews Upromise Industry-Exclusive Agreement 2Cryo-Cell Renews Upromise Industry-Exclusive Agreement 3Cryo-Cell Renews Upromise Industry-Exclusive Agreement 4Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated 2Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated 3
(Date:8/27/2014)... Gamblers are greedy bird-brains, University of Warwick research finds ... when they make risky decisions, new research has shown. ... University of Warwick,s Department of Psychology, conducted tests that ... more likely to gamble for high-value than low-value rewards. ... argue that the test results show the important role ...
(Date:8/26/2014)... have developed algorithms to identify weak spots in tendons, ... technology, which needs to be refined before it is ... strains and tiny injuries in the body,s tissues long ... online Aug. 27 in the Journal of the ... nexus of the physical and life sciences. , "Tendons ...
(Date:8/26/2014)... the University of Warwick have provided the first ... protein is linked to early signs of dementia. ... research found that the absence of the protein ... in the nervous system. These changes were shown ... of dementia, including restricted learning and memory formation ...
Breaking Biology News(10 mins):Gamblers are greedy bird-brains, University of Warwick research finds 2New technology may identify tiny strains in body tissues before injuries occur 2New technology may identify tiny strains in body tissues before injuries occur 3Lack of naturally occuring protein linked to dementia 2
... FRANCISCOSatellite observations have revealed the first direct evidence of ... sheet, tarnishing the ice with soot and making it ... the American Geophysical Union meeting this week, an Ohio ... and Infrared Pathfinder Satellite Observation (CALIPSO) satellite, which captured ...
... most powerful X-ray laser, has revealed the three dimensional structure ... causes African trypanosomiasis (or sleeping sickness) in humans. ... cathepsin B enzyme, it will be possible to design new ... causes sleeping sickness, leaving the infected human unharmed. The ...
... recent University of Colorado Cancer Center review in the journal ... promising cancer prevention properties. Meanwhile, an ongoing clinical trial is ... of colon cancer. "While I have been trained ... to deliver bioactive, cancer fighting compounds with food, and this ...
Cached Biology News:Fire and ice: Wildfires darkening Greenland snowpack, increasing melting 2X-ray laser helps slay parasite that causes sleeping sickness 2Clinical trial tests rice bran to prevent cancer 2
... This goat anti-rabbit IgG FITC ... antibody' for immunofluorescent staining on tissues ... antibody is generated in rabbits. It ... controls, such as omitting the primary ...
1000X solution used for inducing CopyControl™ based vectors to high copy numbers...
Request Info...
HAS1 (C-14)...
Biology Products: